Techniques: Co-crystal structure of an antimicrobial oncocin-derived peptide and bacterial 70S ribosome
Drug platforms
TECHNOLOGY: Crystal structures
Crystallographic studies of Onc112 bound to a bacterial ribosome could guide the design of new therapies to
